CARD: Randomized, open-label study of cabazitaxel (CBZ) vs abiraterone (ABI) or enzalutamide (ENZ) in metastatic castration-resistant prostate cancer (mCRPC)
Year: 2019
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of Oncology
Institutions: Erasmus MC, Medical University of Vienna, Institut Jean Godinot, Université de Reims Champagne-Ardenne, Institute of Cancer Research, Royal Marsden Hospital, Weill Cornell Medicine, Université Paris-Sud, Institut Gustave Roussy, UCLouvain, Asklepios Klinik Altona, Asklepios, National and Kapodistrian University of Athens, Alexandra Hospital, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Azienda Ospedaliera Universitaria Integrata Verona, Palacký University Olomouc, National University Hospital of Iceland, Hôpital Foch, Hôpital d'Instruction des Armées Bégin, Sanofi (United States), Sanofi (France), Hospital Universitario 12 De Octubre
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2977984636